Labiotech ٢٧ مايو ٢٠٢٦ The future of organ transplants: Xenotransplantation, 3D bioprinting and stem cells
Labiotech ٢٥ مايو ٢٠٢٦ Blockbuster sales, lawsuits, and approvals: is there a recovery in sight for Bayer in 2026?
Labiotech ٢٢ مايو ٢٠٢٦ The problem at the heart of drug discovery: Lexogen & Ochre Bio on the power of AI on human data
Labiotech ١٩ مايو ٢٠٢٦ Reducing cell culture contamination: Why sterilisation validation matters in CO₂ shaking workflows